Short answer · Medically reviewed summary · Last updated: 2026-05-08
Frontotemporal degeneration (FTD) is an umbrella term for a group of related conditions caused by progressive nerve cell loss in the brain's frontal and temporal lobes, often historically referred to as Pick's disease. While clinical terminology has evolved to reflect modern neuropathological findings, FTD remains the preferred medical term used by neurologists to describe this spectrum of disorders. What are the historical and alternative names for Frontotemporal Degeneration? In medical literature, you may encounter several terms used to describe Frontotemporal Degeneration.
Frontotemporal degeneration (FTD) is an umbrella term for a group of related conditions caused by progressive nerve cell loss in the brain's frontal and temporal lobes, often historically referred to as Pick's disease. While clinical terminology has evolved to reflect modern neuropathological findings, FTD remains the preferred medical term used by neurologists to describe this spectrum of disorders.
In medical literature, you may encounter several terms used to describe Frontotemporal Degeneration. Historically, the term "Pick’s disease" was used broadly, though it is now specifically reserved for a distinct pathological subtype characterized by Pick bodies. Other names and abbreviations you might find in older medical records or international literature include:
The complexity of nomenclature for Frontotemporal Degeneration stems from its clinical heterogeneity. Because patients present with varying symptoms—ranging from behavioral changes to language impairment—different clinical traditions developed unique names. As our understanding of the proteinopathies (such as Tau, TDP-43, and FUS) has improved, medical professionals have moved toward using Frontotemporal Degeneration to encompass these diverse clinical presentations under a single, unified diagnostic framework.
Today, the term Frontotemporal Degeneration is the standard used by major organizations like the Association for Frontotemporal Degeneration and the NIH. It is preferred because it accurately describes the progressive nature of the disease and its localization in the frontal and temporal lobes, avoiding the potential confusion associated with outdated, narrower diagnostic labels.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always consult with your physician regarding your specific health needs.